Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Daiichi Sankyo Company Limited (4568.T)

AstraZeneca, Daiichi Sankyo Get Positive CHMP Opinion For Enhertu In HER2-Positive Solid Tumours 5/26/2026 2:43:06 AM

FDA Approves AstraZeneca And Daiichi's Datroway For Treating Metastatic Breast Cancer 5/22/2026 11:53:13 AM

AstraZeneca, Daiichi Sankyo's Datroway Gets Approval In US For Treatment Of Breast Cancer 5/22/2026 10:35:34 AM

Daiichi Sankyo & AstraZeneca Win U.S. Approval For Datroway In Metastatic Triple-Negative Breast Cancer 5/22/2026 9:45:52 AM

AstraZeneca: FDA Approves Enhertu For Two New Indications 5/18/2026 2:39:55 AM

AZN :FDA Approves ENHERTU For HER2-Positive Early Breast Cancer In Neoadjuvant And Adjuvant Settings 5/17/2026 11:49:36 AM

Daiichi Sankyo Unveils Five-year Plan Targeting 2.3 Tln Yen Oncology Revenue By 2030 5/11/2026 4:19:09 AM

Daiichi Sankyo Plans To Deliver More Than 2.3 Tln Yen In Oncology Revenue By 2030 5/11/2026 3:49:31 AM

Daiichi Sankyo Expects Annual Results To Improve On Higher Enhertu, Datroway Sales 5/11/2026 3:43:22 AM

Daiichi Sankyo Earnings Fall; Guides FY27 5/11/2026 3:04:27 AM

Daiichi Sankyo Company Limited Profit Retreats In Full Year 5/11/2026 2:45:12 AM

Daiichi Sankyo FY Basic EPS 140.44 Yen Vs 155.96 Yen Last Year 5/11/2026 2:39:55 AM

Wayfinder Biosciences Advances Collaboration With Daiichi Sankyo On Key Neurodegeneration Target To Second Phase 4/15/2026 9:23:51 AM

Daiichi Sankyo: FDA Grants Priority Review For Ifinatamab Deruxtecan 4/13/2026 7:28:02 AM

Daiichi Sankyo, Merck: FDA Grants Priority Review For Ifinatamab Deruxtecan For Treatment Of Adult Patients With ES-SCLC 4/13/2026 7:06:18 AM

Nuvation Bio Acquires Japan Rights For Safusidenib; Now Owns Global Clinical Development Program 4/1/2026 8:14:27 AM

Nuvation Bio Secures Global Rights To Safusidenib With Japan Expansion 4/1/2026 8:06:17 AM

Tempus AI Enters Collaboration With Daiichi Sankyo 3/25/2026 8:52:37 AM

Tempus AI Enters Strategic Collaboration With Daiichi Sankyo To Advance Oncology ADC Program 3/25/2026 8:38:29 AM

Older Articles

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap